Fig. 7From: miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myelomaDecision curve analysis (DCA) underlines the superior clinical benefit of miR-25-fitted multivariate prognostic models. DCA curves of “miR-25-fitted” and “control” multivariate prognostic models for patients’ OS. Net benefit is plotted against various ranges of threshold probabilitiesBack to article page